PATRICIA MAYBORNE: Open Payments
NPI 1063951614 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 56 payments from 11 companies in 2025. Trend: 2023 $1,907 · 2024 $1,266 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 20 | $269 |
| ABBVIE INC. | 12 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $120 |
| Nalu Medical, Inc. | 6 | $101 |
| PROTEGA PHARMACEUTIALS INC | 2 | $82 |
| Boston Scientific Corporation | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Valinor Pharma, LLC | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
Products named: PROCLAIM, QULIPTA, RELISTOR, ETERNA, Nalu Neurostimulation System, ROXYBOND, Intracept, XTAMPZA.
Industry payments across AZ — which companies pay providers there.
